Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cti Biopharm Corp (CTIC)

Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,198,789
  • Shares Outstanding, K 131,880
  • Annual Sales, $ 53,950 K
  • Annual Income, $ -92,990 K
  • 60-Month Beta 0.83
  • Price/Sales 22.62
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CTIC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.58
  • Most Recent Earnings $-0.10 on 05/15/23
  • Next Earnings Date 08/14/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.08
  • Number of Estimates 4
  • High Estimate -0.06
  • Low Estimate -0.09
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +61.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.98 +1.22%
on 05/24/23
9.10 -0.11%
on 06/23/23
+0.10 (+1.11%)
since 05/23/23
3-Month
4.01 +126.97%
on 04/06/23
9.10 -0.11%
on 06/23/23
+4.79 (+111.40%)
since 03/23/23
52-Week
4.01 +126.97%
on 04/06/23
9.10 -0.11%
on 06/23/23
+3.13 (+52.52%)
since 06/23/22

Most Recent Stories

More News
Sobi completes acquisition of CTI BioPharma Corp.

/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) and CTI BioPharma Corp. (NASDAQ:CTIC) (CTI) announced today the completion of the...

CTIC : 9.09 (unch)
Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.

/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) announced today that it has, through its indirect wholly owned subsidiary Cleopatra...

CTIC : 9.09 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, NATI, CTIC, USX

/PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VECT : 16.85 (unch)
NATI : 59.98 (unch)
CTIC : 9.09 (unch)
USX : 6.14 (unch)
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel...

CTIC : 9.09 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, FRG, MMP

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CTIC : 9.09 (unch)
FRG : 29.88 (+0.10%)
MMP : 69.00 (+0.67%)
Moore Kuehn Encourages HMPT, ABST, CTIC and FRG Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

HMPT : 2.32 (unch)
ABST : 11.49 (-0.09%)
CTIC : 9.09 (unch)
FRG : 29.88 (+0.10%)
CTI BioPharma: Q1 Earnings Snapshot

CTI BioPharma: Q1 Earnings Snapshot

CTIC : 9.09 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, MNTV, CTIC, HMPT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FOCS : 52.99 (-0.02%)
MNTV : 9.45 (unch)
CTIC : 9.09 (unch)
HMPT : 2.32 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, LTHM, SYNH, FRG

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CTIC : 9.09 (unch)
LTHM : 16.51 (-8.53%)
SYNH : 42.98 (+0.02%)
FRG : 29.88 (+0.10%)
Why Shares of CTI BioPharma Are Soaring Wednesday

A buyout offer from Swedish Orphan Biovitrum drove up the stock's price.

CTIC : 9.09 (unch)
BIOVF : 27.2100 (+7.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its...

See More

Key Turning Points

3rd Resistance Point 9.11
2nd Resistance Point 9.10
1st Resistance Point 9.10
Last Price 9.09
1st Support Level 9.09
2nd Support Level 9.08
3rd Support Level 9.08

See More

52-Week High 9.10
Last Price 9.09
Fibonacci 61.8% 7.15
Fibonacci 50% 6.55
Fibonacci 38.2% 5.95
52-Week Low 4.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar